Shanghai Kai Kai Industry Co Ltd B (900943) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Kai Kai Industry Co Ltd B (900943) has a cash flow conversion efficiency ratio of 0.007x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.04 Million) by net assets ($582.04 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 900943 net asset quality index to measure how much of total assets are equity-financed.
Shanghai Kai Kai Industry Co Ltd B - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Shanghai Kai Kai Industry Co Ltd B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 900943 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Shanghai Kai Kai Industry Co Ltd B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Kai Kai Industry Co Ltd B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NIGHTINGALE HEALTH EO 1
F:7XE
|
N/A |
|
NDFOS Co. Ltd
KQ:238090
|
-0.005x |
|
Risma Systems AS
CO:RISMA
|
0.209x |
|
Redwood Group Ltd
TWO:8426
|
0.179x |
|
Network-1 Technologies Inc
NYSE MKT:NTIP
|
-0.003x |
|
Cranswick PLC
LSE:CWK
|
0.095x |
|
Rossmax International Ltd
TWO:4121
|
0.044x |
|
4Mass SA
WAR:4MS
|
0.110x |
Annual Cash Flow Conversion Efficiency for Shanghai Kai Kai Industry Co Ltd B (2015–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Kai Kai Industry Co Ltd B from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 900943 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $648.99 Million | $-61.57 Million | -0.095x | -10059.10% |
| 2023-12-31 | $607.20 Million | $578.43K | 0.001x | -99.31% |
| 2022-12-31 | $578.25 Million | $79.34 Million | 0.137x | +180.72% |
| 2021-12-31 | $546.54 Million | $26.71 Million | 0.049x | -68.83% |
| 2020-12-31 | $520.80 Million | $81.66 Million | 0.157x | +293.46% |
| 2019-12-31 | $520.14 Million | $20.73 Million | 0.040x | -37.75% |
| 2018-12-31 | $501.05 Million | $32.07 Million | 0.064x | -55.75% |
| 2017-12-31 | $502.22 Million | $72.65 Million | 0.145x | +533.88% |
| 2016-12-31 | $493.89 Million | $11.27 Million | 0.023x | -2.85% |
| 2015-12-31 | $518.11 Million | $12.17 Million | 0.023x | -- |
About Shanghai Kai Kai Industry Co Ltd B
Shanghai Kai Kai Industry Company Limited engages in the wholesale and retail of pharmaceutical products in China. The company engages in the wholesale and retail of traditional Chinese and Western medicines; medical devices; reagents; consumables and diagnosis; and treatment services, etc. under the Shang Lei brand, as well as production and sale of Chinese patent medicine under the Jing and Que… Read more